Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 27,962 shares at $2.20 ($62K) on 2014-01-07, disclosed to the SEC on 2014-01-08.
Scheduled sale ($62k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |